摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Methyl-2-formyl-cyclohexanon | 26706-86-5

中文名称
——
中文别名
——
英文名称
4-Methyl-2-formyl-cyclohexanon
英文别名
2-Formyl-4-methyl-cyclohexanon;5-methyl-2-oxo-cyclohexanecarbaldehyde;5-Methyl-2-oxo-cyclohexancarbaldehyd;1-Methyl-3-formyl-cyclohexanon-(4);3-Methyl-1-oxymethylen-cyclohexanon-(6);2-formyl-4-methylcyclohexanone;5-Methyl-2-oxocyclohexane-1-carbaldehyde
4-Methyl-2-formyl-cyclohexanon化学式
CAS
26706-86-5
化学式
C8H12O2
mdl
——
分子量
140.182
InChiKey
ITPAXHMRAZLLJP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    90 °C(Press: 5 Torr)
  • 密度:
    1.082±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    34.1
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-Methyl-2-formyl-cyclohexanon草酰氯乙醇sodium 、 lithium hydroxide 作用下, 以 四氢呋喃乙醇氯仿 为溶剂, 反应 2.25h, 生成 5-methyl-4,5,6,7-tetrahydro-benzo[c]thiophene-1-carboxylic acid
    参考文献:
    名称:
    Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes
    摘要:
    Previously, we reported on the discovery of a novel series of bicyclo[3.1.0]hexane fused thiophene derivatives that serve as potent and selective S1P(1), receptor agonists. Here, we discuss our efforts to simplify the bicyclohexane fused thiophene head. In a first step the bicyclohexane moiety could be replaced by a simpler, less rigid cyclohexane ring without compromising the SIP receptor affinity profile of these novel compounds. In a second step, the thiophene head was simplified even further by replacing the cyclohexane ring with an isobutyl group attached either to position 4 or position S of the thiophene. These structurally much simpler headgroups again furnished potent and selective S1P(1) agonists (e.g., 87), which efficiently and dose dependently reduced the number of circulating lymphocytes upon oral administration to male Wistar rats. For several compounds discussed in this report lymphatic transport is an important route of absorption that may offer opportunities for a tissue targeted approach with minimal plasma exposure.
    DOI:
    10.1021/jm401456d
  • 作为产物:
    参考文献:
    名称:
    通过苯磺酰氯与α-二氮酮的αα-加成反应,合成α-(苯硫基)环烯酮和α-苯基-α-(苯硫基)酮的区域特异性合成
    摘要:
    在室温下,环状α-二氮酮与苯磺酰氯反应生成α-氯-α-(苯硫基)环链烷酮,当用三乙胺处理时,α-氯代-α-(苯硫基)环烯酮易于脱氯化氢成α-(苯硫基)环烯酮。无环末端α-二氮酮还提供α-氯代-α-(苯硫基)加合物,它们在合成α-苯基-α-(苯硫基)酮中是有用的亲电子试剂。
    DOI:
    10.1016/s0040-4039(00)81343-x
点击查看最新优质反应信息

文献信息

  • Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
    申请人:Toa Eiyo Ltd.
    公开号:US06258829B1
    公开(公告)日:2001-07-10
    This invention relates to a cycloalka[b]pyridine-3-carbonylguanidine derivative represented by the following general formula (1): and a salt thereof, which can provide a drug having sodium/proton (Na+/H+) exchange transport inhibitory action.
    这项发明涉及一种由以下一般式(1)表示的环烷基吡啶-3-羰基胍衍生物及其盐,该物质可以提供具有钠/质子(Na+/H+)交换转运抑制作用的药物。
  • Regiospecific synthesis of α-(phenylthio)cycloalkenones and of α-phenyl-α-(phenylthio) ketones VIA αα-addition of phenylsulphenyl chloride to ∢-diazoketones
    作者:M.Anthony McKervey、Pinit Ratananukul
    DOI:10.1016/s0040-4039(00)81343-x
    日期:1983.1
    phenylsulphenyl chloride at room temperature to furnish α-chloro-α-(phenylthio)cycloalkanones which undergo ready dehydrochlorination to α-(phenylthio)cycloalkenones when treated with triethylamine; acyclic, terminal α-diazoketones also furnish α-chloro-α-(phenylthio)adducts which are useful electrophiles in the synthesis of α-phenyl-α-(phenylthio)ketones.
    在室温下,环状α-二氮酮与苯磺酰氯反应生成α-氯-α-(苯硫基)环链烷酮,当用三乙胺处理时,α-氯代-α-(苯硫基)环烯酮易于脱氯化氢成α-(苯硫基)环烯酮。无环末端α-二氮酮还提供α-氯代-α-(苯硫基)加合物,它们在合成α-苯基-α-(苯硫基)酮中是有用的亲电子试剂。
  • CYCLOALKA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND DRUGS CONTAINING THE SAME
    申请人:TOA EIYO LTD.
    公开号:EP0972767A1
    公开(公告)日:2000-01-19
    This invention relates to a cycloalka[b]pyridine-3-carbonylguanidine derivative represented by the following general formula (1) : [wherein R1 is hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, an amino lower alkyl group, a lower alkoxyalkyl group, an aryl group, a heterocyclic group, an aralkyl group, a phenoxy lower alkyl group or an aralkyloxy lower alkyl group; R2 is hydrogen atom, a halogen atom, a lower alkoxy group or a nitro group; A is a single bond or a vinylene group; B is a vinylene or the like group; D is a single bond, a methylene group or an ethylene group; and E is a vinylene or the like group] and a salt thereof, which can provide a drug having sodium/proton (Na+/H+) exchange transport inhibitory action.
    本发明涉及一种由以下通式(1)代表的环烷[b]吡啶-3-羰基胍衍生物: [其中 R1 是氢原子、卤素原子、低级烷基、低级烷氧基、氨基低级烷基、低级烷氧基烷基、芳基、杂环基、芳烷基、苯氧基低级烷基或芳氧基低级烷基;R2 是氢原子、卤素原子、低级烷氧基或硝基;A 是单键或乙烯基;B 是乙烯基或类似基团;D 是单键、亚甲基或亚乙基;E 是乙烯基或类似基团]及其盐,可提供一种具有钠/质子(Na+/H+)交换转运抑制作用的药物。
  • Sen-Gupta, Journal of the Chemical Society, 1915, vol. 107, p. 1363
    作者:Sen-Gupta
    DOI:——
    日期:——
  • v. Auwers, Justus Liebigs Annalen der Chemie, 1927, vol. 453, p. 228
    作者:v. Auwers
    DOI:——
    日期:——
查看更多